Development of a biomarker for lung inflammation in COPD through analysis of labelled leukocyte transit through the lung circulation

Development of a biomarker for lung inflammation in COPD through analysis of labelled leukocyte transit through the lung circulation

Measurement of pulmonary leukocyte margination could be a useful biomarker of lung inflammation in COPD, but analysis is complicated by recirculation of labeled leukocytes. 15 minutes of planar nuclear images were obtained after injecting autologous 99mTc-labeled leukocytes in 4 never-smoked control...

Full description

Bibliographic Details
Main Authors:	Emma. H. Baker, Andrew Irwin, Amanda. L. Brennan, Brian Trost, Alan Britten, Sue Heenan, Barry Peterson
Format:	Article
Language:	English
Published:	European Respiratory Society 2006-12-01
Series:	European Respiratory Review
Online Access:	http://err.ersjournals.com/cgi/content/full/15/101/170

Similar Items

Leukocytes are recruited through the bronchial circulation to the lung in a spontaneously hypertensive rat model of COPD.
by: Benjamin B Davis, et al.
Published: (2012-01-01)

Role of Leukocyte-specific protein 1 in acute lung inflammation
Published: (2015)

Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD
by: Li D, et al.
Published: (2019-08-01)

Expression of leukocyte-endothelial adhesion molecules during acute inflammation in the lung
by: Burns, Alan R.
Published: (2008)

Expression of leukocyte-endothelial adhesion molecules during acute inflammation in the lung
by: Burns, Alan R.
Published: (2008)

The mechanisms of wool dust-mediated inflammation and leukocyte activation in the rat lung
by: Brown, David McAllister
Published: (1993)

The association of elevated circulating endocan levels with lung function decline in COPD patients
by: Dai L, et al.
Published: (2018-11-01)

Evaluation of Ventilation-Induced Lung Inflammation Through Multi-Scale Simulations
by: Israr Bin M. Ibrahim, et al.
Published: (2018-01-01)

Bacterial microbiome of lungs in COPD
by: Sze MA, et al.
Published: (2014-02-01)

Lung microbiology and exacerbations in COPD
by: Beasley V, et al.
Published: (2012-08-01)

Lung function decline in COPD
by: Tantucci C, et al.
Published: (2012-02-01)

Platelet-Leukocyte Aggregation in Lung Cancer Patients
by: Meikle, Claire K.
Published: (2019)

Lung Inflammation
Published: (2014)

Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA
by: Michael Offin, et al.
Published: (2017-01-01)

Increased Serum ox-LDL Levels Correlated with Lung Function, Inflammation, and Oxidative Stress in COPD
by: Yongchun Shen, et al.
Published: (2013-01-01)

Analysis of Sputum Markers in the Evaluation of Lung Inflammation and Functional Impairment in Symptomatic Smokers and COPD Patients
by: Gregorino Paone, et al.
Published: (2011-01-01)

Leukocyte-mediated degradation of lung extracellular matrix & serum molecules in chronic inflammatory disease, as discerned through urinary biomarkers
by: Parekh, Gita
Published: (2018)

Physiology and consequences of lung hyperinflation in COPD
by: D. E. O'Donnell, et al.
Published: (2006-12-01)

Lung hyperinflation in COPD: the impact of pharmacotherapy
by: D. E. O'Donnell, et al.
Published: (2006-12-01)

Longitudinal changes in lung hyperinflation in COPD
by: Park J, et al.
Published: (2017-02-01)

Purinergic signaling on leukocytes infiltrating the LPS-injured lung.
by: Daniela Friebe, et al.
Published: (2014-01-01)

Bronchodilator response of advanced lung function parameters depending on COPD severity
by: Jarenbäck L, et al.
Published: (2016-11-01)

Pitfalls in Labelled Leukocyte Scanning
by: H Hodgson, et al.
Published: (1990-01-01)

Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation
by: Wu Y, et al.
Published: (2020-02-01)

Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD
by: Yao Hongwei, et al.
Published: (2010-07-01)

Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients
by: Wu YQ, et al.
Published: (2015-11-01)

Exploring the interplay between airway bacteria, airway inflammation, lung structure and skeletal muscle dysfunction in COPD
by: Barker, Bethan Louise
Published: (2017)

Mycobacterial infection induces higher interleukin-1β and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase.
by: Wen-Cheng Chao, et al.
Published: (2017-01-01)

Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
by: Jian Yin, et al.
Published: (2015-01-01)

Structural changes in the COPD lung and related heterogeneity.
by: Dana Copot, et al.
Published: (2017-01-01)

Dysregulated Functions of Lung Macrophage Populations in COPD
by: Theodore S. Kapellos, et al.
Published: (2018-01-01)

Risk of cancer after lung transplantation for COPD
by: Ekström M, et al.
Published: (2017-10-01)

Analysis of the lung microbiome in the "healthy" smoker and in COPD.
by: John R Erb-Downward, et al.
Published: (2011-02-01)

Factors associated with lung cancer in COPD patients
by: Sandelin M, et al.
Published: (2018-06-01)

COPD depicted – patients drawing their lungs
by: Kaptein AA, et al.
Published: (2017-11-01)

Oxidation of peroxiredoxins in environmental lung injury and COPD
by: Job, Claire
Published: (2011)

COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer)
by: Parrón Collar D, et al.
Published: (2017-03-01)

New Pharmacological Tools to Target Leukocyte Trafficking in Lung Disease
by: Kylie B. R. Belchamber, et al.
Published: (2021-07-01)

Correction: Purinergic signaling on leukocytes infiltrating the LPS-injured lung
by: The Staff
Published: (2014-01-01)

Correction: Purinergic signaling on leukocytes infiltrating the LPS-injured lung.
Published: (2014-01-01)